IP Library › Granted Patent US 12,575,775
Granted Patent B2
US 12,575,775 · App. 17/940,771 · Granted Mar 17, 2026

Intra-body electrode with a poly(3,4-ethylenedioxythiophene)-based coating

Inventor: Alan Shi (Plymouth, MN)
Assignee: Medtronic, Inc.
A61B5/268A61B5/6847A61B2562/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,575,775
App. No.
17/940,771
Granted
Mar 17, 2026
Kind
B2
Abstract

Embodiments in accordance with the present disclosure are directed to an apparatus comprising an intra-body electrode, and a poly(3,4-ethylenedioxythiophene) (PEDOT)-based coating. The PEDOT-based coating is on a surface of the intra-body electrode. And, the PEDOT-based coating includes a PEDOT-backbone doped with counter ions and cross-linked to a photoreactive polymer and a photoreactive-hydrophilic polymer.

Claims (31)

1 . An apparatus, comprising:

an intra-body electrode; and

a poly(3,4-ethylenedioxythiophene) (PEDOT)-based coating on a surface of the intra-body electrode, the PEDOT-based coating including a PEDOT-backbone doped with tetrafluoroborate (TFB) counter ions and cross-linked to a photoreactive polymer and a photoreactive-hydrophilic polymer;

wherein the intra-body electrode with the PEDOT-based coating is configured to provide a capacitance of at least sixty microfarad per square millimeter (μF/mm 2 ) and to exhibit a relative difference in impedance magnitude at ten kilohertz (kHz) and at ten Hz of five percent or less.

2 . The apparatus of claim 1 , further including an elongate conduit, wherein the intra-body electrode is positioned on an exterior surface of the elongate conduit.

3 . The apparatus of claim 1 , wherein the photoreactive polymer is non-charged and is configured to provide passivation against protein and cell adhesion when the intra-body electrode is implantable, and the intra-body electrode is configured to capture physiological signals.

4 . The apparatus of claim 1 , wherein the intra-body electrode includes a conductive material and the photoreactive-hydrophilic polymer is non-charged and is a hydrogel configured to provide lubricity and wettability to the PEDOT-based coating on the surface of the intra-body electrode.

5 . The apparatus of claim 1 , wherein the capacitance is at least seventy microfarad per square millimeter (μF/mm 2 ).

6 . An apparatus, comprising:

an intra-body electrode; and

a poly(3,4-ethylenedioxythiophene) (PEDOT)-based coating on a surface of the intra-body electrode, the PEDOT-based coating including a PEDOT-backbone doped with tetrafluoroborate (TFB) counter ions, the intra-body electrode with the PEDOT-based coating configured to provide a charge storage capacity of at least 360 microcoulomb per square millimeter (μC/mm 2 ) and up to 902 μC/mm 2 .

7 . The apparatus of claim 6 , wherein the intra-body electrode with the PEDOT-based coating is further configured to provide a total charge storage capacity of at least five hundred microcoulomb per square millimeter (μC/mm 2 ) and up to 902 microcoulomb per square millimeter (μC/mm 2 ).

8 . The apparatus of claim 6 , wherein the intra-body electrode with the PEDOT-based coating is further configured to maintain electrode potentials within a water stability window and minimize electrode polarization under electrical stimuli.

9 . The apparatus of claim 6 , further including:

an elongate conduit that carries electrically conductive wires; and

a plurality of intra-body electrodes positioned on an exterior surface of the elongate conduit and coupled to the electrically conductive wires, the plurality of intra-body electrodes including the intra-body electrode with the PEDOT-based coating and being configured to capture physiological signals and to deliver electrical signals.

10 . The apparatus of claim 6 , wherein the PEDOT-backbone doped with TFB counter ions is cross-linked to a photoreactive polymer and a photoreactive-hydrophilic polymer.

11 . A method, comprising:

a. adding a layer of poly(3,4-ethylenedioxythiophene) (PEDOT)-based polymer on an intra-body electrode using a solution, the layer of PEDOT-based polymer including PEDOT doped with counter ions and cross-linked to a photoreactive polymer, wherein the counter ions include tetrafluoroborate (TFB);

b. incorporating a photoreactive-hydrophilic polymer with the layer of PEDOT-based polymer; and

c. curing the layer of PEDOT-based polymer to the photoreactive-hydrophilic polymer to form a PEDOT-based coating on the intra-body electrode, the PEDOT-based coating including the PEDOT doped with the counter ions and cross-linked to the photoreactive polymer and the photoreactive-hydrophilic polymer;

d. wherein the intra-body electrode with the PEDOT-based coating is configured to provide a capacitance of at least sixty microfarad per square millimeter (μF/mm 2 ) and to exhibit a relative difference in impedance magnitude at ten kilohertz (kHz) and at ten Hz of five percent or less.

12 . The method of claim 11 , wherein incorporating the photoreactive-hydrophilic polymer with the layer of PEDOT-based polymer includes dip coating the intra-body electrode with the layer of PEDOT-based polymer in a solution that includes the photoreactive-hydrophilic polymer dissolved in a solvent.

13 . The method of claim 11 , wherein curing the layer of PEDOT-based polymer to the photoreactive-hydrophilic polymer includes exposing the layer of PEDOT-based polymer with the incorporated photoreactive-hydrophilic polymer on the intra-body electrode to ultraviolet light for a period of time.

14 . The method of claim 11 , further including curing an additional amount of the photoreactive polymer to the layer of PEDOT-based polymer.

15 . The method of claim 11 , further including forming the solution by dissolving a 3,4-ethylenedioxythiophene (EDOT) monomer in a solvent, wherein the solution includes the EDOT monomer, the photoreactive polymer, the counter ions, and the solvent.

16 . The method of claim 12 , wherein the solution includes tetrabutylammonium tetrafluoroborate (TBATFB), and the solvent includes acetonitrile, and the PEDOT-based coating includes a PEDOT:TFB structure cross-linked to the photoreactive polymer and the photoreactive-hydrophilic polymer.

17 . The method of claim 11 , wherein adding the layer of PEDOT-based polymer includes electrochemically depositing the PEDOT doped with the counter ions on a surface of the intra-body electrode using the solution, wherein the PEDOT doped with the counter ions on the surface of the intra-body electrode includes a PEDOT:tetrafluoroborate (TFB) structure that passively incorporates the photoreactive polymer.

18 . The method of claim 17 , wherein electrochemically depositing the layer includes depositing the PEDOT doped with the counter ions using potentiostatic electrochemical deposition by applying a voltage for a period of time to the intra-body electrode while the intra-body electrode is submerged in the solution.

19 . The method of claim 17 , wherein electrochemically depositing the layer includes depositing the PEDOT doped with the counter ions using cyclic voltammetry between a voltage range and at a scan rate for a number of cycles.

20 . The method of claim 17 , further including curing the PEDOT doped with the counter ions to the passively incorporated photoreactive polymer to form the layer of PEDOT-based polymer including the PEDOT doped with the counter ions cross-linked to the photoreactive polymer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2022
From: SHI, ALAN
To: MEDTRONIC, INC.
Reel/Frame 061030/0083 →
Continuity (2)
Provisional Application 63248719 · Sep 27, 2021
Related Publication 20230101016A1 · Mar 30, 2023
References Cited (34)
US 5131388A · Pless et al. · 1992 [cited by applicant]
US 5144949A · Olson · 1992 [cited by applicant]
US 5158078A · Bennett et al. · 1992 [cited by applicant]
US 5199428A · Obel et al. · 1993 [cited by applicant]
US 5207218A · Carpentier et al. · 1993 [cited by applicant]
US 5314430A · Bardy · 1994 [cited by applicant]
US 5330507A · Schwartz · 1994 [cited by applicant]
US 5331966A · Bennett et al. · 1994 [cited by applicant]
US 5354316A · Keimel · 1994 [cited by applicant]
US 5447519A · Peterson · 1995 [cited by applicant]
US 5509411A · Littmann et al. · 1996 [cited by applicant]
US 5545186A · Olson et al. · 1996 [cited by applicant]
US 5699796A · Littmann et al. · 1997 [cited by applicant]
US 5967978A · Littmann et al. · 1999 [cited by applicant]
US 6021340A · Randolph et al. · 2000 [cited by applicant]
US 6163723A · Roberts et al. · 2000 [cited by applicant]
US 6198952B1 · Miesel · 2001 [cited by applicant]
US 8777942B2 · Wu et al. · 2014 [cited by applicant]
US 8888773B2 · Chang et al. · 2014 [cited by applicant]
US 8998894B2 · Mauch et al. · 2015 [cited by applicant]
US 9037238B2 · Stadler et al. · 2015 [cited by applicant]
US 9370311B2 · Stewart et al. · 2016 [cited by applicant]
US 10245429B2 · Deem et al. · 2019 [cited by applicant]
US 10328243B2 · Spear et al. · 2019 [cited by applicant]
US 10426377B2 · Markowitz et al. · 2019 [cited by applicant]
US 10561845B2 · Giftakis et al. · 2020 [cited by applicant]
US 20160208114A1 · Hendricks · 2016 [cited by examiner]
US 20200377756A1 · Taton et al. · 2020 [cited by applicant]
US 20210345928A1 · Stoica · 2021 [cited by examiner]
WO 2019152415 · 2019 [cited by applicant]
WO 2021076054 · 2021 [cited by applicant]
Mandal, H. et al. “Improved Poly(3,4-Ethylenedioxythiophene) (PEDOT) for Neural Stimulation”. Neuromodulation: Technology at the Neural Interface. Jan. 27, 2015. (Year: 2015). [cited by examiner]
Extended European Search Report for Application No. 22196944.7 dated Feb. 20, 2023 (8 pages). [cited by applicant]
Mandal et al., “Improved Poly(3,4-Ethylenedioxythiophene) (PEDOT) for Neural Stimulation”, Neuromodulation, vol. 18, No. 8, Dec. 1, 2015, pp. 657-663. [cited by applicant]